Khaled Musallam I Luspatercept for Beta-Thalassemia: Updates from Recent Trials I 2022

Luspatercept for Beta-Thalassemia: Updates from Recent Trials Khaled Musallam, MD PhD Group Chief Research Officer, VPS Healthcare, Abu Dhabi, UAE Adj. Professor Khalifa University, Abu Dhabi, UAE Founder, Evida Medical, Dubai, UAE President, International Network of Hematology, London, UK The 23rd Egyptian Thalassemia Association Conference 24-25 May 2022 Grand Nile Tower Hotel- Cairo

Видео Khaled Musallam I Luspatercept for Beta-Thalassemia: Updates from Recent Trials I 2022 автора Gaming Challenges